ABT vs PFE

A side-by-side look at ABT and PFE, updated throughout the trading session.

ABTABT Open ABT on Vela

PFEPFE Open PFE on Vela

Performance, normalized

Z-scored closes: both paths on one scale, price levels aside.

Loading history…

Live figures are refreshing. Check back in a moment.

ABT vs PFE: how they differ

Abbott Laboratories (ABT) and Pfizer Inc. (PFE) are both in the Healthcare sector: ABT is classified in Medical - Devices, PFE in Drug Manufacturers - General. Both trade on NYSE.

ABT trades about 10.5 million shares a day on average, against 38.6 million for PFE. ABT has the higher beta (0.58 against 0.28 for PFE), meaning it has historically moved more with the broad market. Over the trailing twelve months, ABT paid $2.52 per share in dividends and PFE paid $1.72 per share.

Figures as of October 26, 2026.

The chart Z-score-normalizes each closing series, computing (close − mean) ÷ standard deviation over the window, so both paths share one scale regardless of price level, and correlation is computed on daily returns. Figures update throughout the trading session. Nothing on this page is financial advice.